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Pharmaceutical Polymorph Control in a Drug-Mimetic 
Supramolecular Gel 
Jonathan A. Foster,
a
 Krishna K. Damodaran,
b
 Antoine Maurin,
c
 Graeme M. Day,*
d
 Hugh P. G. 
Thompson,
e
 Gary J. Cameron,
c
 Jenifer Cuesta Bernal
c
 and Jonathan W. Steed*
c 
We report the synthesis of a bis(urea) gelator designed to specifically mimic the chemical structure of the highly 
polymorphic drug substance ROY. Crystallization of ROY from toluene gels of this gelator results in the formation of the 
metastable red form instead of the thermodynamic yellow polymorph. In contrast, all other gels and solution control 
experiments give the yellow form. Conformational and crystal structure prediction methods have been used to propose 
the structure of the gel and shows that the templation of the red form by the targetted gel results from conformational 
matching of the gelator to the ROY substrate coupled with overgorwth of ROY onto the the local periodic structure of the 
gel fibres. 
Introduction 
The control of the solid state properties of crystalline drugs is 
of tremendous importance to the pharmaceutical industry. 
Active ingredient polymorphic form, particle size and crystal 
morphology profoundly influence the material’s solubility, 
compressibility, friability, melting point, hygroscopy, bulk 
density and dissolution rate.1-3 Polymorph control also offers 
scope to transform an amorphous or hard-to-crystallise active 
pharmaceutical ingredient (API) into a readily handled, stable 
crystalline solid and is vital in obtaining regulatory approval.4 
Examples of drug substances in which late-appearing or slow to 
nucleate polymorphs (as in the case of ritonavir5 or 
clopidogrel6) show that it can be very difficult to ensure that all 
possible crystal forms have been discovered. Moreover reliable 
identification and characterisation of polymorphic forms early 
in development can avoid lengthy and costly legal disputes as 
in the cefdinir case.7  
 In addition to careful removal of possible contaminating 
‘seeds’ and highly controlled, reproducible crystallization 
conditions,8 advanced crystallization techniques such as 
crystallization from microemulsion droplets can in some cases 
reliably and selectively nucleate particular solid forms such as 
the thermodynamic form under ambient conditions.9 However 
there remains a significant need for solid form screening 
techniques that can target hard-to-nucleate polymorphs.  
 Crystallization in polymer hydrogels (e.g. agar, silica gel) of 
inorganic materials such as calcium carbonate10-14 and of 
biomolecules such as proteins is a well-known technique in 
which the gel limits convection and prevents sedimentation, 
allowing continuous, diffusion-limited growth15 and spatial 
control of nucleation.16 The gel environment can influence a 
number of factors such as crystal habit, polymorphism and 
enantiomorphism.17-21 Hydrogels22 have also been used to 
crystallise pharmaceuticals such a modafinil23 and the highly 
polymorphic model compounds ROY and carbamazepine have 
been crystallized within cubic polyethylene glycol diacrylate 
microgel particles.18  
 We have reported a novel polymorph discovery technique 
involving drug crystal growth in supramolecular organogels.24 
25, 26 Supramolecular gels offer a number of potential 
advantages over traditional polymeric hydrogels including the 
diverse range of functional groups that can be incorporated, the 
wide range of solvent gels and the ability to redissolve the gels 
in order to recover the crystals.  There have been a few recent 
reports of crystallization within low molecular weight 
supramolecular gels,21 notably work by Estroff on calcite 
crystallization in a bis(urea) gel,10 work by Gunnlaugsson on 
salt nanowires27 and work by Sanchez involving crystallization 
of aspirin, caffeine, indomethacin and carbamazepine in 
toluene-based tetraamide organogels28 and in lysine-based 
dendrons.20 In none of this work is there any suggestion of the 
gelators being designed to mimic the crystallization substrate 
and the gelator, although carboxylates have been suggested to 
mimic carbonate in calcium carbonate hydrogel 
crystallizations.29 As a result the gel and crystal self-assembly 
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are essentially orthogonal or only very weakly coupled and any 
differences in polymorphism observed serendipitous.21, 30 
 We hypothesised that incorporating molecular features into 
a gelator that mimic those of the growing crystal would 
increase the probability of influencing crystal growth. In the 
present work we report the design of targeted bis(urea) gelators 
that gel to give a fibre surface that chemically mimics a target 
model drug substance, ROY,31 and offers the possibility of 
epitaxial crystal overgrowth and hence templation of metastable 
or hard-to-nucleate solid forms in a bespoke, drug-specific 
manner. 
 ROY was first synthesised by Eli Lilly as a precursor to 
olanzapine, a schizophrenia drug.32 There are at least ten crystal 
forms of ROY of which seven have been crystallographically 
characterised and are kinetically stable enough to be studied 
under near-ambient conditions.33 In fact, a crystal structure 
prediction study of the ROY molecule has demonstrated that 
even further polymorphs might be possible.34 The colours of the 
ROY polymorphs originate from conformational isomerism and 
allow for relatively facile in-situ monitoring, with the yellow 
prism form (Y) being the most stable under ambient 
conditions.35 The substance also exhibits piezochromism.36 
ROY represents a particularly suitable model system because of 
its large diversity of polymorphs, difficulty in controlling the 
crystallization outcome because of seeding effects and 
concomitant polymorphism, and its conformational 
polymorphism37 which offers the possibility of conformational 
matching with a targeted gel. Indeed one ROY polymorph has 
already been discovered by epitaxial nucleation.32 
Results and Discussion 
 
Scheme 1. ROY and ROY-mimetic bis(urea) gelators 1 and 2.  
We have designed a series of gelators incorporating o-
nitroaniline-derived functional groups, mimicking the o-
nitroaniline substituent in ROY, grafted onto a variety of 
bis(urea) gel-forming cores. We anticipate that these targeted 
gelators will self-assemble to give gels38, 39 in which the surface 
of the gel fibre consists of a locally ordered array of o-
nitroaniline-derived functional groups, closely matching the o-
nitroaniline substituent in ROY. The series of bis(urea) 
compounds were readily prepared from the reaction of o-
nitrophenylisocyanate with five different diamine cores (see 
supplementary material, Scheme S1). The compounds were 
tested for gelation in a variety of solvents and compounds 1 and 
2 were found to be effective gelators, whereas the other three 
compounds failed to gel the majority of the solvents tested and 
were not further investigated (see supplementary information). 
While bis(ureas) commonly give high aspect ratio solid 
particles, the evolution of these fibrillar materials into gels is 
subject to solubility constraints and a subtle balance of 
interactions that are not currently fully understood.40-42  
 Compound 1 formed gels at 1 % weight to volume in almost 
all solvents studied (acetonitrile, methanol, ethanol, acetone, 
dichloromethane, chloroform, ethyl acetate and toluene). Gels 
were not observed in water or THF. However, the gels are 
opaque and fragile, breaking apart to form a precipitate if 
gently shaken. The chloroform, toluene, acetonitrile and 
acetone gels are unstable and form a precipitate after a number 
of days whilst gels from other solvents remain stable. The 
opacity of these gels renders them unsuitable for crystallization 
studies and as a result efforts concentrated on compound 2.  
 Compound 2 forms robust, stable, translucent gels in a wide 
range of solvents (see supplementary material) including 
acetonitrile, methanol, acetone, ethyl acetate and toluene as 
shown in Figure 1. Compound 2 is much less soluble than 1 
failing to dissolve fully in a number of the solvents at 1 % w/v. 
Undissolved material tends to inhibit gel formation and the use 
of lower concentrations of gelator results in more translucent 
and homogeneous gels. SEM studies on the xerogel show an 
entangled network of fine fibres. The small translucent 
appearance of the gels makes them highly suited to 
crystallization studies. Moreover the fact that this gelator can 
gel a range of organic solvents allows a great deal of scope to 
co-dissolve the gelators with drug substances of varying 
solubility.24 
 
Figure 1. (a) organogels formed by 2 in (left to right) dichloromethane, 
chlorobenzene, 1,2-dichlorobenzene, benzene, toluene, acetonitrile, methanol, 
ethanol, 1-propanol, 1-butanol, nitrobenzene and ethyl acetate (b) SEM 
micrograph of the toluene xerogel of 2 at 1 % w/v. 
Solutions containing 100 mg/mL of ROY were crystallised by 
slow cooling from toluene gels of the designer gelator 2, as well 
(a) 
(b) 
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as under the same conditions from toluene control solutions 
containing either no gelator, or one of four different bis(urea) 
gelators (3 – 6) with no structural similarity to ROY. These 
non-specific gelators contained substituents derived from L-
alanine (3),43 L-phenylalanine (4),44 L-lysine (5) and 
triethoxysilane (6)45 instead of the ROY-mimetic 
nitrophenylanaline-derived substituent (see supplementary 
material for gelator structures). A further gelator with a L-
phenylalanine substituent and the same diphenylmethane 
derived spacer as 2 (compound 7) was also prepared. Toluene 
was selected as the solvent because a wide variety of the 
gelators reliably form gels in the solvent without sonication. 
Samples were heated in sealed vials until all material was 
dissolved and allowed to cool to room temperature on the bench 
top. 
After leaving the samples for one month all of the non-
specific generic gelators and the solution control experiment 
produced large yellow blocks identified by single crystal X-ray 
unit cell determination, IR spectroscopy and XRPD (see 
supplementary information Figures S1 and S2) as the 
thermodynamically most stable monoclinic Y form. Under the 
same conditions, 1 % w/v gels of 2 produced red crystals 
corresponding to the metastable, triclinic red (R) form, also 
characterised by unit cell determination, IR and XRPD. Figure 
2 shows images of the crystals obtained from different gels. 
These results indicate that the designer gelator, 2, induces the 
crystallisation of a different polymorph of ROY to that obtained 
from solution or from a range of gels with no structural 
similarity to ROY. 
Figure 2. (a) Crystals of ROY grown from four non-specific control gels and from 
gels of 2 (left to right: 3, 4, 5, 6 and 2) and a solution phase control experiment. 
(b) Isolated gel-grown crystals of the Y and R forms. (c) Y-form crystals growing in 
a toluene gel of non-specific gelator 6 (left) and R-form crystals growing in 
toluene gel of 2, (right; arrows point to individual crystals). 
 In order to test the generality and reproducibility of this 
observation, crystallizations of ROY in toluene at 
concentrations 50 – 200 mg/mL were undertaken from gels of 
ROY mimic 2. The outcome of these experiments were 
compared with samples crystallized from solution and from 
four different non-specific gelators bearing either amino acid 
substituents (3, 4 and 7) or triethoxysilane terminal groups (6) 
as well as different spacer units between the urea 
functionalities. Gels were formed with 1 % w/v of gelator in 
each case except for compound 3, which was used at 1.5 % 
w/v. An additional sample containing a non-gelling solution 
saturated with 2 at room temperature was also investigated. The 
purpose of this reference was to test whether any differences 
observed were due to the gel state or compound 2 acting as a 
solution-based crystallization additive.  
 The crystallisations were repeated in a series of experiments 
between 5 and 12 times and the results detailed in ESI Tables 1 
and 2 and the collated results for samples loaded with 100 
mg/mL ROY are summarised in Figure 3. The optimised 
experimental setup involved addition of 1 mL toluene to the 
gelator (10mg) and ROY (100mg) in a vial, which was then 
sealed and heated to 140 ⁰C to avoid heteroseeding. A DrySyn 
Multi-reaction was used to station in order to achieve a 
consistent, controlled cooling profile. Crystallisation generally 
took place over several hours to weeks. Clear differences in 
crystal colour and shape allow the different polymorphs to be 
distinguished. Solid forms were confirmed by IR spectrometry 
and XRPD analysis. Analyses of the crystals revealed two 
different polymorphs identified as the Y and R forms,46 
sometimes appearing concomitantly. All the crystals formed 
were stable and did not undergo any phase transition in situ 
after several months.  
Gels of 2 loaded with 100 mg/mL ROY yielded the 
metastable R form is almost every case, with only two of the 
twelve repeats giving the Y form. These two anomalous results 
are attributed to accidental heteroseeding with Y particles. In 
contrast, the vast majority of samples from the control gelators 
produced the Y form (which is the most thermodynamically 
stable under ambient conditions). The control experiments in 
toluene devoid of any gelator also resulted in the 
thermodynamic Y form. Gelator 3 produced four Y and one R 
samples out of five whilst the remaining one gave a 
concomitant mixed R/Y sample. Gelator 4 gave one 
concomitant R/Y sample, with one sample transforming to Y 
after three days and remaining six yielded Y crystals. Gelator 6 
gave only Y crystals. Gelator 7, which has the same spacer 
between the bis(urea) but a phenylalanine derived end group 
unrelated to ROY, and therefore potentially provides the best 
comparison, gave the Y form in five repeats whilst one gave the 
R form and one a mixture of the R and Y forms.  
 Samples crystallised at lower concentrations of ROY (50 
mg/mL) typically took longer to crystallise and the R form was 
only observed from gels of 2 with all other samples giving the 
Y form.  In contrast, at 200 mg/mL of ROY, only the Y form 
was observed in gels of 2 indicating high concentrations may 
diminish the gel’s selectivity.   
 The solution controls only gave the Y form (18 repeats). 
The Y form was also obtained in three out of five 
crystallizations from solutions of gelator 2 at a concentration 
too low to result in gel formation. This suggests that compound 
2 has only a small effect on crystal growth as a solution based 
additive and it is the solid fibres of gels of 2 that induce 
formation of the R form.  
 On balance this screen suggests that the designer gels of 2 
strongly bias ROY crystallization towards formation of the 
metastable triclinic red R form. The difficulty in controlling 
(c) (b) 
(a) 
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ROY polymorphic outcome from solution is well 
documented.31, 33 In one study a solution of ROY evaporated 
from 10,000 500 μm gold islands on a single plate produced six 
out of the seven stable forms of ROY.47 An additional factor is 
that in some samples the crystals grow against the sides of the 
vials and on the surface of the gels. In these cases 
heteronucleation on the glass vial or from dust at the gel surface 
may determine the crystal form rather than the influence of the 
gel matrix. The microscopic seeding of the Y form is also a 
potential confounding factor. In this context, the results are 
remarkably clear-cut indicating that the ROY-mimetic 
nitrophenylaniline substituent exerts a clear influence on the 
crystallization outcome. 
 In order to understand the mechanism by which gels of 2 
consistently produce a different polymorphic outcome in the 
crystallization of ROY compared to other bis(urea) gels and 
solution control experiments we compared the structure of 2 
with the crystal structures of the R and Y forms of ROY. The 
tendency of 2 to form highly anisotropic gel fibres means it is 
not possible to characterise 2 by single crystal X-ray diffraction 
and powder diffraction gives broad, poorly defined peaks (see 
supplementary information). We therefore applied 
computational structure prediction methods to investigate the 
molecular geometry of 2. The conformational flexibility of 2 
means that structural determination in this way remains highly 
challenging. 
Figure 3. (a) Collated data comparing the form of ROY obtained from 100 mg/mL 
toluene gels of designer gelator 2, non-specific gelators 3, 4, 6 and 7, from 
toluene solution saturated with 2 and from solution. R+Y denotes concomitant 
crystallisation of both the R and Y crystal forms in the same sample. (b) 
Crystallization of the Y form of ROY from a toluene gel of control compound 7 
and the R form from a toluene gel of 2 (arrows point to individual crystals). 
The conformational landscape of 2 was predicted using force 
field based searches, using the OPLS-AA force field within a 
low-mode conformational search,48 followed by dispersion-
corrected density functional theory (DFT-D) molecular 
geometry optimization.  These searches found a large number 
of possible conformers, the lowest energy of which adopt a 
compact geometry in which nitroaniline groups on each end of 
the molecule are folded together. However, a recent 
computational study49 has demonstrated that flexible molecules 
preferentially adopt higher energy, extended conformers in the 
solid state, which enables greater intermolecular interactions. 
We calculate the Connolly surface area of all structures as a 
measure of the extendedness of the conformer (Fig. 4). Many 
extended conformers are available within the relevant energy 
range for conformers in solids (approximately 25 kJ mol-1),49 
which open the nitroaniline groups to a more accessible 
arrangement. Although we cannot select one of the predicted 
conformers as that which forms the gel, we propose that the 
fibres are composed of one of these extended conformers of 2.  
As a predictor of which conformer is most likely, it has been 
suggested that a biasing term based on the surface area is added 
to the DFT-D conformational energies to approximate the 
increased stabilizing intermolecular interactions available to 
extended conformations.49 The preferred conformer with this 
term included is shown in the blue box in Figure 4.   
Interestingly, few of the candidate conformers of 2 
exhibited the urea conformation that is required to form the 
common urea -tape type of packing mode based on the 
ubiquitous 𝑅2
1(6)  hydrogen bonded ring geometry.39, 50, 51 A 
relatively small number of predicted conformers have one of 
the urea groups in an anti-anti conformation (Fig. 4), where 
both hydrogen atoms are oriented anti to the carbonyl oxygen. 
The lowest energy conformer with both ureas in the anti-anti 
conformation is found 85 kJ mol-1 above the lowest energy 
conformer (off the scale of Figure 4). These results suggest that 
it is unlikely that the gel fibres form as a consequence of strong 
uni-directional hydrogen bond tapes.  
Figure 4. Conformational landscape of gelator 2. Each point represents the 
calculated (DFT-D) energy and Connolly surface area of a predicted conformer. 
Selected conformers are shown, with all hydrogen atoms hidden for clarity, apart 
from the urea hydrogens. Red points show conformations with one urea group in 
the anti-anti conformation. No conformations with both ureas in the anti-anti 
conformation are found in this energy range. The predicted most likely 
conformation, as a balance of intramolecular energy and extendedness, is 
enclosed in a blue box. 
 Intramolecular hydrogen bonds from the urea to nitro 
groups are present in all low energy conformers of 2, forming 
6-membered rings which would be predicted by Etter’s 
hydrogen bonding rules.52 These intramolecular hydrogen 
(a) 
(b) 
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bonds might be expected to interfere with intermolecular 
hydrogen bonding.  
 To explore the solid state packing of 2, crystal structure 
prediction (CSP) calculations were performed on a selection of 
the lowest energy and most extended predicted conformers. 
Previous work has shown that CSP methods designed to predict 
crystal structure can help understand the molecular arrangement 
in gel fibres.53-55 The CSP calculations involved a quasi-random 
search56 for structures in a set of commonly observed space 
groups, followed by lattice energy minimization with the 
CrystalOptimizer57 and DMACRYS58 software, using an 
atomic multipole based atom-atom force field. Most of the 
lowest energy predicted crystal structures from both the folded 
and extended molecular conformers contained 𝑅2
2(8) 
NH…O=C hydrogen bond rings involving the non-
intramolecularly hydrogen bonded urea hydrogen. These 
dimeric interactions at each end of the molecule result in 
infinite chains (Fig. 5a), which would be expected to lead to 
fast growth in the direction of the chain. 
 We then attempted to correlate the CSP results with the 
experimental XRPD pattern obtained from xerogels of 2. While 
XRPD data for xerogels is generally broad and featureless 
because of the lack of long range order in gel fibres, we 
obtained similar XPRD patterns from xerogels of 2 from a 
range of solvents suggesting that gels of 2 adopt a similar 
structure regardless of solvent. The xerogel XRPD data did not 
prove to be a match for any of the calculated structures 
involving the folded conformer, however the XRPD patterns 
corresponding to the lowest energy calculated structures of the 
extended conformers possessed considerable similarity to the 
experimental xerogel XRPD data (see supplementary 
information). Hence there is justification for regarding packing 
features of the lowest energy calculated crystal structures of the 
extended conformer of 2, and particularly the hydrogen bond 
chains of molecules, as a model for the way in which 
compound 2 packs in the gel fibrils. 
Figure 5. a) Hydrogen bond chains in the lowest energy predicted crystal 
structure resulting from an extended conformer of 2. Hydrogen bonds are 
indicated as thin blue lines. The conformer leading to this structure is enclosed in 
a blue box in Figure 4.b) Overlay of the extended conformer of 2 with the ROY 
conformation from the R polymorph, showing a good steric match of the 
nitroaniline group to ROY. c)  Overlay of the extended conformer of 2 with the 
ROY conformation from the Y polymorph, The thiophene rings and urea are 
nearly at right angles, showing a poor steric match. 
 The intramolecular hydrogen bonding maintains planar 
nitroaniline units at either end of the gelator molecule, which 
extend outwards from the hydrogen bonded chains of molecules 
(Fig. 5a). Therefore, the nitroaniline would be expected to be 
exposed on the surface of gel fibres, thus being available for 
interaction with ROY molecules. Significant differences 
between ROY polymorphs lie in the dihedral angle between the 
phenyl and thiophene rings, and it is these conformational 
differences that are responsible for the distinctive colours of the 
different solid forms. Figure 5 shows an overlay of the 
molecular structure of 2 taken from this calculated structure 
with the molecular structures of ROY observed in the Y and R 
experimental crystal structures, matching the nitrophenyl 
groups in the two molecules. The thiophene orientation in the R 
conformation gives a close steric match to the urea in 2 and 
aligns the polar thiophene sulfur with the urea oxygen (Fig. 5b). 
In contrast, the Y conformation places the thiophene at right 
angles to the urea group in 2 (Fig. 5c). Thus, 2 gives a better 
steric and electrostatic match to the R than the Y conformation 
of ROY. This is a result of the intramolecular hydrogen bond, 
present in all low energy conformers of 2, which strongly 
favours the nearly-coplanar arrangement of urea and 
nitrophenyl groups. In the proposed structure of 2, these groups 
are presented periodically on the surface of the gel fibres 
allowing them to interact with the growing nucleus. We thus 
hypothesise that the ability of gels of 2 to template the R form 
from a supersaturated solution of ROY arises from a match of 
the R conformer with the periodic structure of the ROY-
mimetic portion of the gelator resulting in epitaxial overgrowth 
of this metastable form. The effect of conformational matching 
between the gelator and ROY for R would be weakened if the 
gelator conformation was flexible and likely to be dynamic at 
the surface of the gel fibre. However, conformational dynamics 
of the nitroaniline group are expected to be minimised by the 
intramolecular hydrogen bond and the rigidity of the urea 
group. The other control gels are likely to adopt the more 
conventional urea -tape type packing and do not possess 
chemical functionality that can interact with ROY in 
supersaturated solution. As a result, the polymorphic outcome 
is the same as the solution control experiments. 
Conclusions 
In conclusion, organogels of a specifically targeted gelator that 
mimics the functional groups of the highly conformationally 
polymorphic substrate ROY reproducibly results in the 
crystallization of the metastable R polymorph of ROY. Under 
identical conditions, crystallization from generic gels, from 
solution and from solutions containing the designer gelator at 
sub-critical gelation concentration all give the thermodynamic 
Y form. The likely structure of the designer gelator 2 was 
calculated using conformation and crystal structure prediction 
methodologies to give insight into the structure matching 
between gel and the ROY forms. The unique effect of designer 
gels of 2 is postulated to arise from conformational matching 
with the pendant ROY-mimetic functional groups on the gel 
fibre surface, coupled with the local periodicity of the gel fibre 
allowing heteronucleation of the R form. This study 
demonstrates the potential of designer supramolecular gels to 
be used in a targeted way to influence the polymorphism of 
pharmaceutical compounds. 
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